Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation (Q84705027)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 2009
edit
Language Label Description Also known as
English
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
scientific article published on 01 November 2009

    Statements

    Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit